This is the authors' abstract. We don't add key points for this paper.
Resistance to antineoplastic drugs may develop through a variety of mechanisms, including deletion of membrane-transport mechanisms, an increase in target-enzyme concentration, or a deletion of an essential drug-activating enzyme. One unique mechanism for mutation to drug resistance is amplification of the gene coding for a target protein, leading to elevated levels of the protein. In studies of cultured experimental tumor-cell lines, resistance to a variety of toxic substances, including cadmium1 and the antineoplastic drugs N-phosphonacetyl-L-aspartate2 and methotrexate,3 has been ascribed to gene amplification.The process of gene amplification in methotrexate-resistant mammalian cells may occur within a single chromosome, producing an . . .
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Curt et al. (1983) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: